2018 대한부정맥학회 심방세동 환자에서 NOAC 사용 지침: 처방의 시작과 유지
2018 KHRS Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Korean Patients with Atrial Fibrillation: How to Initiate and Organize the Follow-up
박진규, 김준, 백용수, 이소령, 황유미, 김태훈, 이대인, 이기홍, 심재민, 정보영,
소속 상세정보
박진규 ( Park Jin-Kyu )
한양대학교병원 심장내과
김준 ( Kim Jun )
울산대학교 의과대학 서울아산병원 심장내과
백용수 ( Baek Yong-Soo )
인하대학교병원 순환기내과
이소령 ( Lee So-Ryoung )
순천향대학교병원 심장내과
황유미 ( Hwang You-Mi )
가톨릭대학교 성빈센트병원 순환기내과
김태훈 ( Kim Tae-Hoon )
연세대학교 의과대학 세브란스병원 심장내과
이대인 ( Lee Dae-In )
Chungbuk National University
이기홍 ( Lee Ki-Hong )
전남대학교병원 순환기내과
심재민 ( Shim Jae-Min )
고려대학교 의과대학 고려대학교 안암병원 순환기내과
정보영 ( Joung Bo-Young )
연세대학교 의과대학 세브란스병원 심장내과
Abstract
Non-vitamin K antagonist oral anticoagulants (NOACs) are alternatives to vitamin K antagonists to prevent stroke in patients with non-valvular atrial fibrillation (AF) and have emerged as the preferred choice. The use of NOACs is rapidly increasing in Korea after coverage by insurance since 2015. However, the rate of prescribing anticoagulants in Korean patients with AF remains low compared to other countries. Most of the NOAC anticoagulant prescriptions are issued at hospitals. As the prevalence rate of AF in Korea is expected to increase rapidly with the increase in the elderly population, the need to prescribe NOACs in primary care clinics will also increase. Therefore, The Korean Heart Rhythm Society organized the Korean Atrial Fibrillation Management Guideline Committee and analyzed all available studies based on the 2018 European Heart Rhythm Association Practical Guide on the use of NOACs for managing AF, as well as studies on Korean patients. The authors would like to introduce practical guidelines for NOAC prescriptions in Korean patients with AF.
키워드
Atrial fibrillation; Anticoagulant; Practice guideline
원문 및 링크아웃 정보
등재저널 정보